123 related articles for article (PubMed ID: 17227571)
1. Renal allograft protection with angiotensin II type 1 receptor antagonists.
Tylicki L; Biedunkiewicz B; Chamienia A; Wojnarowski K; Zdrojewski Z; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Transplant; 2007 Jan; 7(1):243-8. PubMed ID: 17227571
[TBL] [Abstract][Full Text] [Related]
2. Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.
Tylicki L; Biedunkiewicz B; Chamienia A; Wojnarowski K; Zdrojewski Z; Rutkowski B
Transplantation; 2006 Jan; 81(1):52-6. PubMed ID: 16421476
[TBL] [Abstract][Full Text] [Related]
3. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
[TBL] [Abstract][Full Text] [Related]
4. [Comparative effects of carvedilol, losartan and their combination in preventing left ventricular remodeling after acute myocardial infarction in rats].
Yang Y; Tang Y; Ruan Y; Li Y; Gao R; Chen Z
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):811-4. PubMed ID: 16206669
[TBL] [Abstract][Full Text] [Related]
5. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Profibrotic Gene Expression by Angiotensin Receptor Blockers.
Nafar M; Samavat S; Shahraki E
Iran J Kidney Dis; 2018 Nov; 12(6):369-375. PubMed ID: 30595567
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.
Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G
J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710
[TBL] [Abstract][Full Text] [Related]
8. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
9. Effect of losartan on slowing progression of chronic allograft nephropathy.
Wang PX; Fan MQ; Huang CB; Feng JY; Xiao Y; Fang ZQ; Zhang YP
Chin Med Sci J; 2005 Dec; 20(4):231-6. PubMed ID: 16422249
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II blockade in kidney transplant recipients.
Ibrahim HN; Jackson S; Connaire J; Matas A; Ney A; Najafian B; West A; Lentsch N; Ericksen J; Bodner J; Kasiske B; Mauer M
J Am Soc Nephrol; 2013 Feb; 24(2):320-7. PubMed ID: 23308016
[TBL] [Abstract][Full Text] [Related]
11. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Abdallah HH; Johns EJ
Eur J Pharmacol; 2009 Jun; 612(1-3):69-74. PubMed ID: 19356722
[TBL] [Abstract][Full Text] [Related]
13. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
[TBL] [Abstract][Full Text] [Related]
14. Short-term Effects of Losartan on Cardiovascular Risk and Allograft Injury Biomarkers in Kidney Transplant Recipients.
Kuźmiuk-Glembin I; Heleniak Z; Pięta R; Głyda M; Lizakowski S; Renke M; Konopa J; Chamienia A; Biedunkiewicz B; Rutkowski B; Tylicki L; Dębska-Ślizień A
Transplant Proc; 2022 May; 54(4):981-988. PubMed ID: 35346485
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol, losartan and trimetazidin on functional parameters of isolated heart of rats at oxidative stress.
Antelava N; Gabunia L; Gambashidze K; Petriashvili Sh; Bejitashvili N
Georgian Med News; 2009 Feb; (167):81-4. PubMed ID: 19276478
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
17. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Khan MA; Abdullah NA; Johns EJ
Acta Physiol (Oxf); 2009 Mar; 195(3):397-404. PubMed ID: 19183357
[TBL] [Abstract][Full Text] [Related]
18. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
19. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
20. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.
Kurokawa K; Chan JC; Cooper ME; Keane WF; Shahinfar S; Zhang Z
Clin Exp Nephrol; 2006 Sep; 10(3):193-200. PubMed ID: 17009077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
